• Français
  • INVEST IN OUR FUTURE
  • INVEST IN OUR FUTURE
  • INVEST IN OUR FUTURE

A targeted investment strategy

Xerys is a portfolio management company specialising in private equity with an approach that makes the entrepreneur’s vision central to its investment philosophy. It aims to support the managers of Xerys Funds portfolio companies at all stages of their growth, from venture capital to maturity.

JACQUES SIMONNET

JACQUES SIMONNET

Chairman of the supervisory board and founder

OLIVIER OSSIPOFF

OLIVIER OSSIPOFF

Chairman

OUR PHILOSOPHY

The Xerys approach

« The creation of Xerys aims to meet the need to reconcile two major issues for business growth. On the one hand, entrepreneurs who wish to successfully carry out their growth ambitions need tailored, financial guidance but also strategic and operational support. On the other hand, investors are looking for transparency and control of their investments.…


OUR STRATEGY

AN ORIGINAL APPROACH TO A CAPITAL INVESTOR

100%

INDEPENDENT


10-80M€

INVESTMENT
TICKET


6

PORTFOLIO
COMPANIES

2014

Approval of the Authority
Financial Markets

Strong expertise

The governance of Xerys Invest is structured around a supervisory board and a directory with complementary experiences

Strong involvement

The management team and the experts are involved in the monitoring of the participations

Convergent interests

The management team is systematically interested in the performance of investments

Xerys therefore immediately establishes a constructive and proactive proximity relationship with the managers of its investments to assist and advise them in their strategic decision-making, arbitration and value creation.
With this original approach, Xerys establishes a relationship of trust with managers and investors, fostering a creation of shared value over the medium term.

3 SECTORS OF INVESTMENT


Santé


Sustainable
development


Connected
Technologies

NEWS

Biolog-id

Biolog-id Announces Deployment of its Value-Chain-Optimization Solution at We Are Blood, a Major Blood Center Serving Central Texas

The deployed solution will provide digital visibility and improved control over multiple points of the value-chain for blood products ...
Read more
Biolog-id

New Hanover Regional Medical Center in North Carolina, part of Novant Health integrated delivery network, begins phase one of deploying Biolog-id’s value-chain optimization solution

Preliminary deployment covers the management of Red Blood Cell (RBC) and Platelet (PLT) inventories in the central Blood Bank, as ...
Read more
Skytech participation développement durable

SKYTECH launches its international deployment and announces the opening of a first subsidiary in Italy

 Le Val d'Hazey, July 7, 2022 – SKYTECH, a French Greentech player specialized in the production of premium regenerated resins ...
Read more

OUR PARTICIPATIONS

XERYS FRANCE

73 boulevard haussmann

75008 Paris - France

+33 (0)1 82 52 12 25

FOLLOW-US: